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Abstract 
 
The present study aimed to isolate Helicobacter pylori and conduct the susceptibility 
tests  to Commiphora myrrh in comparison with widely used antibiotics. The study 
samples were collected from Sudanese patients who were suffering from peptic disease 
during the period September 2006 to November 2007 in Ibn Sina T. Hospital.  
The study population was 52 females and 48 males their ages ranged between 19 and 70 
years. It was observed that high prevalence of Helicobacter pylori infection in old ages . 
The study included 32 manual worker, 31 house wives and 15 students , 6 farmers and 
16 other jobs (Doctors ,Employers ,Engineers and Teachers). Helicobacter pylori was 
isolated in sixty of the total of one hundred specimen collected. The sensitivity tests 
were done against Amoxicillin, tetracycline ,Metronidazole and Clarithromycin by disk 
diffusion method and Commiphora myrrh extraction by agar dilution in four dilution 
1/20,1/40,1//80 and 1/160. It was found that 71% of isolates were sensitive to 
Amoxicillin, 61.7%Tetracycline ,38.3% to Metronedazole and35% to  Clarithromicin ,In 
Commiphora myrrh dilution one (1/20)which highist sensitivity rate  100% . Dilution 
two(1/40) 90% .50% for dilution three(1/80). And 20 % for dilution four (1/160) . That 
means that Amoxicillin is the best choice  and the MIC of Commiphora myrrh extraction 
is  1/20  and Commiphora myrrh may be examined as an alternative treatment against 
Helicobacter pylori .  
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  ﺒﺴﻡ ﺍﷲ ﺍﻟﺭﺤﻤﻥ ﺍﻟﺭﺤﻴﻡ
   
  ﻤﺴﺘﺨﻠﺹ ﺍﻷﻁﺭﻭﺤﺔ
  
 ﻤـﺎ ( ﻟﻤﺭ ﻫﺎﺭﺒـل ) ﺩﺭﺠﺔ ﺤﺴﺎﺴﻴﺘﻬﺎ  ﻭﺩﺭﺍﺴﺔ ( ﺒﻴﻠﻭﺭﻯ ﺘﺭ ﺍﻟﻬﻴﻠﻜﻭﺒﺎﻜ ) ﻟﻌﺯل ﻤﻴﻜﺭﻭﺏ  ﺍﻟﺤﺎﻟﻴﺔ  ﺍﻟﺩﺭﺍﺴﺔ ﺩﻓﺕﻫ
  . ﻴﻌﺭﻑ ﻓﻰ ﺍﻟﺴﻭﺩﺍﻥ ﺒﺎﻟﻤﺭ ﺍﻟﺤﺠﺎﺯﻯ ﻤﻘﺎﺭﻨﺔ ﺒﺎﻟﻤﻀﺎﺩﺍﺕ ﺍﻟﺤﻴﻭﻴﺔ ﺍﻻﻜﺜﺭ ﺍﺴﺘﺨﺩﺍﻤﺎ ﻓﻰ ﺍﻟﻌﺎﻟﻡ
ﺴﻭﺩﺍﻨﻴﻴﻥ ﻴﻌﺎﻨﻭﻥ ﻤﻥ ﺍﻟﻘﺭﺤﺔ ﺍﻟﻤﻌﺩﻴﺔ ﺨـﻼل ﺍﻟﻔﺘـﺭﺓ ﻤـﻥ ﺃﺠﺭﻴﺕ ﺍﻟﺩﺭﺍﺴﺔ ﻋﻠﻰ ﻋﻴﻨﺎﺕ ﺍﻨﺴﺠﺔ  ﻤﻥ ﻤﺭﻀﻰ 
  . ﺒﻤﺴﺘﺸﻔﻰ ﺍﺒﻥ ﺴﻴﻨﺎ ﻗﺴﻡ ﺍﻟﻤﻨﺎﻅﻴﺭ 7002 ﺍﻟﻰ ﻨﻭﻓﻤﺒﺭ6002ﺴﺒﺘﻤﺒﺭ 
 ﺴﻨﺔ ﻭﻭﺠـﺩﺕ ﺍﻻﺼـﺎﺒﺔ 07 ﺍﻟﻰ 91 ﻤﻥ ﺍﻟﺭﺠﺎل ﺘﺘﺭﺍﻭﺡ ﺍﻋﻤﺎﺭﻫﻡ ﺒﻴﻥ 84 ﻤﻥ ﺍﻻﻨﺎﺙ ﻭ 25ﺸﻤﻠﺕ ﺍﻟﺩﺭﺍﺴﺔ 
  .ﺒﺎﻟﻬﻴﻠﻭﻜﻭﺒﺎﻜﺘﺭ ﺒﻴﻠﻭﺭﻯ ﺍﻜﺜﺭ ﺸﻴﻭﻋﺎ ﻓﻰ ﺍﻻﻋﻤﺎﺭ ﺍﻻﻜﺒﺭ 
 61 ﻤﺯﺍﺭﻋﻴﻥ ﻭ 6 ﻤﻥ ﺍﻟﺘﻼﻤﻴﺫ ﻭ 51 ﻤﻥ ﺭﺒﺎﺕ ﺍﻟﺒﻴﻭﺕ 13 ﻤﻥ ﺍﺼﺤﺎﺏ ﺍﻻﻋﻤﺎل ﺍﻟﺤﺭﺓ ﻭ 23ﺩﺭﺍﺴﺔ ﻭﺸﻤﻠﺕ ﺍﻟ 
  (ﺒﺎﺀ ﻤﻬﻨﺩﺴﻴﻥ ﻭﻤﺤﺎﻤﻴﻴﻥ ﻭ ﻤﻌﻠﻤﻴﻥ ﺍﻁ) ﻤﻥ ﺍﻟﻤﻬﻥ ﺍﻻﺨﺭﻯ 
ﻟﻠﻤﻀﺎﺩﺍﺕ ﺍﻟﺤﺴﺎﺴﻴﺔ ﻋﺯﻟﺕ ﺒﻜﺘﺭﻴﺎ ﺍﻟﻬﻠﻜﻭﺒﺎﻜﺘﺭ ﺒﻴﻠﻭﺭﻯ ﻤﻥ ﺴﺘﻴﻥ ﻋﻴﻨﺔ ﻤﻥ ﻤﺠﻤﻭﻉ ﻤﺎﺌﺔ ﻭﺍﺠﺭﻱ ﻟﻬﺎ ﺍﺨﺘﺒﺎﺭ 
ﺒﻁﺭﻴﻘﺔ ﺍﻨﺘﺸﺎﺭ ﺍﻻﻗﺭﺍﺹ ﺍﻟﻤـﺸﺭﺒﺔ ﻭﻟﻠﻤـﺭ ( ﻭﻜﻼﺭﻴﺜﺭﻭﻤﺎﻴﺴﻥ ﻭﻤﻴﺘﺭﻭﻨﻴﺩﺍﺯﻭل ﺍﻤﻭﻜﺴﺴﻠﻴﻥ ﻭﺘﺘﺭﺍﺴﻴﻜﻠﻴﻥ )ﺍﻟﺤﻴﻭﻴﺔ 
 ﻭﻭﺠﺩ ﺍﻥ ﻨـﺴﺒﺔ ﺍﻟﺘﺤـﺴﺱ 061/1 ﻭ 08/1 ﻭ 04/1ﻭ02/1ﺍﻟﺤﺠﺎﺯﻯ ﺒﻁﺭﻴﻘﺔ ﺘﺨﻔﻴﻑ ﺍﻻﻗﺎﺭ ﺒﺎﻟﺘﺨﻔﻴﻑ ﺍﻟﻤﻀﺎﻋﻑ 
ﻟﻠﻜﻼﺭﻴﺜﺭﻭﻤﺎﻴـﺴﻥ ﻭﺒﺎﻟﻨـﺴﺒﺔ ﻟﻠﻤـﺭ %  53ﻭ% 3.83ﻭﻟﻠﻤﻴﺘﺭﻭﻨﻴﺩﺍﺯﻭل % 16ﻭﻟﻠﺘﺘﺭﺍﺴﻴﻜﻠﻴﻥ% 17ﻟﻼﻤﻭﻜﺴﺴﻠﻴﻥ 
% 05 ﻭ (04/1)ﻟﻠﺘﺤﻔﻴﻑ ﺍﻟﺜﺎﻨﻰ % 09ﻭ( 02/1)ﻓﻰ ﺍﻟﺘﺤﻔﻴﻑ ﺍﻻﻭل  %001ﻁﻰ ﺘﺤﺴﺱ ﻋﺎﻟﻰ ﺒﻨﺴﺒﺔ ﺍﻟﺤﺠﺎﺯﻯ ﺍﻋ 
  %  02  (061/1 ) ﻭﻜﺎﻨﺕ ﻨﺴﺒﺔ ﺍﻟﺘﺤﺴﺱ ﻓﻲ ﺍﻟﺘﺨﻔﻴﻑ ﺍﻟﺭﺍﺒﻊ ﻭﺍﻻﺨﻴﺭ(08/1 )ﻟﻠﺘﺨﻔﻴﻑ ﺍﻟﺜﺎﻟﺙ
  ﺍﻟـﺫﻯ ﻭﺍﻥ ﺍﻗل ﺘﺭﻜﻴﺯ ﻟﻠﻤﺭ ﺍﻟﺤﺠـﺎﺯﻯ . ﻴﻥ ﻠﻫﺫﺍ ﻴﻌﻨﻰ ﺍﻥ  ﺍﻻﻤﻭﻜﺴﺴﻠﻴﻥ ﻭﺍﻟﺘﺘﺭﺍﺴﻴﻜﻠﻴﻥ ﻫﻤﺎ ﺍﻟﺨﻴﺎﺭﻴﻥ ﺍﻻﻓﻀ 
ﻟﻬﻠﻜﻭﺒـﺎﻜﺘﺭ ﺍ)  ﻀـﺩ ﺒﺩﻴلﺨﺘﺒﺭ ﻜﻌﻼﺝ  ﻜﻤﺎ ﺍﻨﻪ ﻴﻌﻨﻰ ﺍﻥ ﺍﻟﻤﺭ ﺍﻟﺤﺠﺎﺯﻯ ﻴﻤﻜﻥ ﺍﻥ ﻴ ، 02/1ﻴﺜﺒﻁ ﻨﻤﻭ ﺍﻟﺒﻜﺘﺭﻴﺎ ﻫﻭ 
  .  (ﺒﻴﻠﻭﺭﻱ
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Introduction and Literature  review 
 
1.1 Peptic Ulcer:   
 A peptic ulcer is a sore on lining 0f the stomach or duodenum which is the beginning 
of small intestine .It refer to an ulcer in the lower esophagus ,stomach, duodenum in 
jejunum after surgical anastonsis to stomach or rarely in the  ileum adjacent to 
meckel’s divverticulum ,in acid and pepsin play major pathogenic role(1,2 ). An ulcer 
in the lining of the stomach is called a gastric ulcer and the ulcer on upper part of the 
small intestine or duodenum called duodenal ulcer. In the US, duodenal ulcers are three 
times more common than gastric ulcers.                                  
The lining of the stomach is a layer of special cells, chemicals and mucous that 
prevents the stomach from being damaged by its own acid and digestive enzyme. If 
there  is a break or ulcer in the lining, the tissue under the lining can be damaged by the 
enzymes and corrosive acid . If the ulcer is small ,there may be few symptoms and the 
wound can heal on its own .If the ulcer is deep ,it can cause serious pain or bleeding 
and may eat completely through the stomach or duodenum wall.                                     
The ulcers are common world wide , it may affect up to10-15 % of the population at is 
variable but it is very common in Scotland and northern England more than in southern 
England ,is also common in India (3,4) and common in Africa especially in the west, 
and usually the most affected patient present with complication ,incidence of P.U.D is 
declining in the world especially the complicated type but still the gastric ulcer is 
common in the east especially in Japan ( pre-malignant ulcer ) (5),              
The prevalence of peptic ulcer is decreasing in many western communities. It sill 
affects at some time approximately 10% of all adult males. The male to female ratio for 
duodenum ulcer varies from 5:1 to2:1 in different communities while that for gastric 
ulcer is 2:1 or less (2). In Sudanese patients peptic ulcer was found in 17% of 2500 
upper gastrointestinal endoscopies (6) in other study on 12443 upper gastrointestinal 
endoscopies the active duodenal ulcer was 10-8% with seasonal variation seen with 
great incidence in January, February and lower incidence in July, August in 
comparison with the rest of year .(1,7,8).in other studies in Sudan the prevalence of 
P.U.D is about 18-30% so it is a very common disease .It effects predominantly, the 
younger age group of which   a large number of patient presented with complications 
(3,9)      Katelaris et al .,(10) in heir study of dyspepsia ,H. pylori and                            
 peptic ulcer in the randomly selected population in India found that prevalence of 
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active peptic ulcer in 197 male subjects was 6,6%   with a further 6,6%of subjects has 
definite evidence of scaring or deformity   (10) .In Misra et al.(11) study in India on H. 
pylori positive asymptomatic healthy subjects were 2,8% (11) .                 
  
In Italian (12) study The prevalence was as higher as  22% in a group of 121 
individuals with H. pylori infection (12) in asymptomatic healthy blood donors                               
Peptic ulcer is common in every 10 Americans develops an ulcer of some time in his or 
her life. The main cause of an ulcer is bacterial infection but some ulcers were caused 
by long- term use of non steroidal anti-inflammatory agents (NSAID) like aspirin and 
ibuprofen . In few cases, cancerous tumors in stomach or pancreas can cause ulcer . 
 
1.1.2 causes of peptic ulcer : 
The major factor to be examined are H. pylori ,non-steroidal anti-inflammatory drugs 
(NSAIDs),smoking stress ,alcohol ,dietary factors ,physical activity and heredity (13) .                  
Since the Nobel prize-winning demonstration of the role of H. pylori in peptic ulcer 
,there has been a widespread assumption that H. pylori is the cause of P.U and so 
implicitly of the epidemic (13,14) Baron and Sonnenberg (15) have suggested an 
epidemic of a potent strain of H. pylori sweeping the world was the cause of the ulcer 
epidemic ,and there are temporal, geographic and theoretical arguments to support this.                  
The people infected with H. pylori have arlativ risk of 1.6-5.7 (mean 3.3)of developing 
PU compared with non-infected people (13,16,17) calculation of the population 
attributable risk (ie, the proportion  of disease cases that can be attributed to a particular 
factor) shows that ,in recent series, H, pylori accounts for only about 50% of peptic 
ulcer (18) .                       ` 
Non-steroidal anti-inflammatory drugs (NSAIDs) (13,19,20). Despite  a large body of 
evidence suggesting a role of non-steroidal anti-inflammatory drug (NSAIDs) in 
causing ulcer especially in elderly women (13).                 
  
long− term use of non steroidal anti−inflammatory drugs (NSAIDs) is  the second most 
common cause of ulcers .About 5-10% of duodenal           
ulcer disease patients and 30% of gastric ulcer patients do not have evidence of H 
.pylori infection .these ulcer presumably due to ASA, NSAIDs or some other agents of 
injury(13).About tow of every three patient on long-term NSAIDs have some gastro 
duodenal mucosal lesions. most of which were superficial (corrosions, rhanguse,etc) 
(3,13)                                      
Non-steroidal anti-inflammatory drugs (NSAIDs) provide effective management of pain 
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and inflammation ,but are associated with the formation of peptic ulcer and increased 
risk of peptic ulcer hemorrhage and perforations (serious gastrointestinal events)in the 
range o.3%to2.5% per year(20,21,22)    
Lifestyle Factors.: Although lifestyle factors (e.g. chronic stress ,dietary factor 
,smoking ).                                                                                                                         
Smoking : there is evidence that smoking increased  the risk of peptic ulcer .An OR of 
2.2 is typical ,and a 40-year study of male doctors in the U.k has shown a threefold 
increase in the risk of death from peptic ulcer in current smokers.(13,29)                                         
Alcohol : there is little evidence of an association between alcohol use and peptic ulcer 
.A study of Doll et al found no association in 13 year of follow-up (13,25).                                     
With coffee  ,sugar ,salt there is little evidence of a link between them and duodenum 
ulcer (26,27,28)                                                           .                                                                       
Hereditary : A role of hereditary factor in peptic is Cleary delineated by several 
Scandinavian studies of large groups of monozygonic and dizygonic twins, reared 
together and separately .the evidence indicates that 39% -62% susceptibility to peptic 
ulcer is explained by hereditary factor ,the rest by environmental ones (29,30).There is 
also a major role for heredity in H. pylori acquisition (63% attributable to genetic 
factors), but genetic influences for developing peptic ulcer independent of those for 
acquiring H .pylori and the transition of H. pylori positivity to peptic ulcer is due to 
environmental factor (31).                                                                                            
Stress : The sparse evidence for a link between stress and peptic ulcer is beset with 
methodological problem .A follow-up of 5388people in the first US National Health 
and Nutrition Examination Survey (1986-1992)found a clear positive dose –response 
curve . Those with the highest level of stress had an adjusted a relative risk of 
developing peptic ulcer (31).                                
-  The least common major cause of peptic ulcer disease is the Zollinger−Ellison 
syndrome (ZES).\ among patients with peptic ulcers. The mean age at onset is 45 to 50 
years, and men are affected more often than women.                                                                         
ZES should be suspected in patients with ulcers who are not infected with H .pylori  
and have no history of NSAID use.                                     
-Rarely, certain conditions may cause ulceration in the stomach or intestine , including                  
· Radiation treatments.                                                                       
· Bacterial or viral infections.                                                              
· At 50 years old or older .                                                                
· Physical injury.                                                                             
. Burin                                                                                           
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1.1.3 Symptoms of peptic ulcer :                                                
Pain is the most common symptom. The pain usually:      
Is a dull, gnawing ache; 
Comes and goes for several days or weeks; 
Occurs 2 to 3 hours after a meal; 
Occurs in the middle of the night (when the stomach is empty) , and is relieved by 
food.  
1.1.3.1 Other symptoms:  
Other symptoms of peptic ulcer include  
Weight loss. 
Poor appetite. 
Bloating. 
Burping. 
Nausea. 
Vomiting.  
Some people experience only very mild symptoms, or none at all.                            
1.1.3.2 Emergency Symptoms : 
Sharp, sudden, persistent stomach pain. 
Bloody or black stools. 
Bloody vomit or vomit that looks like coffee grounds. 
They could be signs of a serious problem, such as: 
Perforation-when the ulcer burrows through the stomach or duodenal wall. 
Bleeding - when acid or the ulcer breaks a blood vessel. 
Obstruction - when the ulcer blocks the path of food trying to leave the stomach  .                          
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1.1.5 Treatment of peptic ulcer: 
Treatment of peptic ulcer is currently in astate of major change .In the past therapy 
that consisted of acid-neutralizing or acid- secretary inhibiting drugs was useful to 
control the symptoms. (3).                                                                                                                   
people whose ulcers are caused by NSAIDs or other drugs should stop using these 
drugs. Healing will begin almost immediately. Also medications are recommended to 
reduce acid damage during  healing .These may include anti-acids to neutralize 
gastric acid or medications that decrease the amount of acid produced by the stomach. 
1.2 Helicobacter : 
In the aearly 1980s, Warren and Marshal, two Australian physicians, reported the 
presence of an unidentified gram-negative curved and spiral-shaped bacillus in gastric 
epithelial tissue of patient with chronic gastritis .Originally called Campylobacter 
pylori this organism was later renamed Helicobacter pylori when the organism was 
found to have characteristics that differed from those of true Campylobacters (33).. 
In 1982. Warren and Marshal were the first to culture and identify what is now known 
as H .pylori and to establish the association between the presence of this organism in 
mucosa and occurrence of histological gastritis (34,35). Within a few years of 
publication of  Warren and Marshal’s work many reports appeared worldwide. 
confirming the close association between H .pylori and chronic active gastritis .as well 
as with gastric and duodenal ulcer .The historical association between bacteria and 
peptic ulcer disease are described by Rathbone and Heatley (1992) (34) The organism 
was named Campylobacter pyloridis by Marshal et al (1994).but this was later changed 
to the more grammatically correct Campylobacter pylori. Further studies showed that 
the organism sufficiently from true Campylobacter to justify the formation of a new 
genus Helicobacter.(34,36).It soon became apparent that similar organism colonized 
the stomach of a wide variety of animals other than humans .and  certain spiral bacteria 
colonized intestines of rodents and other animals belonged to Helicobacter 
.Helicobacter and Campylobacter, Arcobacter and Wolinella was shown to belong to a 
distinct bacterial grouping. RRNA super family VI .based on 16s RNA-DNA 
hybridization analysis(37) and the classification was defined by 16s r DNA phylogenic 
analysis which placed Helicobacter and these other genera in the epsilon subclass of 
class proteobacteria . Although specific fatty acid profile .specific ultra structure. 
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Respiratory quinines. growth requirements and enzyme characteristics were  originally 
described to distinguish Helicobacters .the use of 16s rDNA analysis is crucial for their 
classification as there are no other consistent taxonomic markers to facilitate separation 
of Helicobacter from allied genera such as Campylobacter and Arcobacter.  
Helicobacter pylori infects about half of the world’s population. was widely accepted 
as a cause for the development of gastritis (38,39,40). Today, H. pylori is not only 
considered a causative agent of chronic type B gastritis and peptic ulcer disease, but 
also an important risk factor for gastric cancer and MALT-lymphoma . 
1.2.1 Characteristics: 
H. pylori is a curved or spiral shaped Gram negative bacillus with up to three windings 
(40). It measures 3-5 µm in length and approximately 0.5 µm in diameter. There are 
two to six unipolar sheathed flagella (41), which are essential for the bacterium’s 
motility. Under unfavorable conditions H. pylori can transform into a coccoid form, 
which probably reflects degenerative changes (42). The microaerophilic bacterium 
possesses both oxidase and catalase activities. The complete genome of a H. pylori 
strain was sequenced by Tomb et al .  (1997) (43 ) 
1 2.2 .Habitat :  
Humans appear to be the only natural host of H. pylori identified to date, although 
some studies suggest that animals also may act as a reservoir, as reviewed by Mitchell 
(38,44). 
The surface of the stomach mucosa is the major habitat of H. pylori and the majority 
are located adjacent to surface and pit gastric epithelial cells (34) 
1.2.3  Species : 
There are more than 20 species ascribed io the Helicobacter genus. Chronic infection 
of various host with gastric Helicobacters  such a H. pylori, H. felis ,H. mustelae and 
H. bizzozeronii has been associated with a spectrum of pathologies such as gastritis, 
mucosa-associated lymphoid tissue lymphoma(45,46,47)and in the case of H .pylori , 
peptic ulcer and gastric adenocarcenoma in humans (48,49).Other related bacteria 
such as H. hepaticus, H. bilis, H. pullorum and Helicobacter sp flexispira colonize the 
enterohepatic niche of animals and humans, and many play role in enterohepatic and 
gastroenteritis (50,51).And other spp such as H.acinonychiis  ,H.nemestrinae,H  
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.mustelae   ,H.heillmannii,H.canadensis andH.bills ,H.bovis ,H. suis and H. Suncus 
(34)  
 
2.2.4  Antigenic  structures: 
Helicobacter have the typical cell wall structure of gram- negative bacteria comprised 
of lipopolysaccharide (LPS) attatched to a semi permeable outer membrane 
apeptidoglycan layer .and an inner cell membrane. The fatty acid composition of H. 
pylori is distinctive and one of the main criteria for Campylobacter’s .It is characterized 
by long –chain fatty acid composed predominantly of tetradecanoic (14 :0) and 19-
carbon cyclopropan (19-0cyc)acid acids with lower amounts of hexadecanoic (16:0) 
octadecanoic (18:0) . octadecanoic (18:1) and linoleic (18:2 )acid Phosphatidylethanol-
amine (79.1%) .lysophosphatidylethanolamine (16%).and phosphatidylcholine (1.9%) 
constitute the polar head groups of neutral phospholipids. Acidic phospholipids contain 
phosphatidic acid (52.7% )and phosphatidylserine (47.3%) H. pylori does not possess 
the methyl-substituted menaquinones (thermo plasma quinones ) present in 
Campylobacter species. Cholesterol glycosides are a unique characteristic of the lipid 
content of various Helicobacter sp.(34,52)  
1.2.5 culture and colony morphology : 
                                                                                                                                                               
H. pylori is strictly microaerophilic and Co2 (5-20%)and high humidity are required for 
growth.(34,53 ) H. pylori requires media containing supplements similar to those used 
for Campylobacter blood .serum .starch .or charcoal. However H. pylori is inhibited by 
bisulfate in the ferrous sulfite-sodium metabisulfite -sodium pyruvate (FBP) 
Campylobacter  ‘aerotolerance’ supplement .(34) 
The good growth has been obtained by using Brucella, brain-heat infusion (BHI) and 
cryptic Soya agar with 5% sheep blood and using of modified Thayer- martin agar as a 
selective media for isolation of  Helicobacter pylori  in mixed cultures incubated at 
37oC.in humid microphilics environment (5% O and 10% Co2 and 85% N2 ) for 3 - 6 
days.(53) 
Poor growth is observed on commercially prepared chocolate agar and there for this 
media is not recommended because Helicobacter pylori  is susceptible to cephalothin 
and will not grow on any selective media containing cephalosporin.   
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The colonies of Helicobacter pylori   are small, they grow bigger than 2mm in diameter 
if incubation extended beyond 1week. gray, translucent, convex (34,53) weekly B-
hemolytic. on 5%horse blood agar. motility is weak or absent when grow on agar.(34) 
Gram stain reveals pale-staining curved gram-negative with characteristic gull-wing 
and U shapes. 
 
1.2.6 Pathogenesis :  
H. pylori does not invade the host tissue but rather is restricted to the mucus overlaying 
the gastric epithelium. During its colonization of the gastric mucosa H. pylori is 
challenged by the innate and adaptive immune response, and the organism has 
developed strategies of avoidance and subversion of the immune system. The virulence 
factors described above support the organism’s ability to establish a persistent 
infection, but mechanisms of immune evasion such as antigenic shedding of urease, 
antigenic variation and a possible immune suppression by H .pylori may contribute as 
well . 
Urease in an important immunodominant protein that makes its way to the cell surface, 
where it is not covalently attached (54), and free urease or urease adsorbed to bacteria 
has been detected in the gastric mucosa of H. pylori infected patients (55,56). Shed 
urease could bind to secretory IgA and thereby overcome its antibacterial activity . 
After the sequencing of the H. pylori genome, sequence similarities among a group of 
outer membrane proteins have become evident. It seems feasible that recombination 
events could lead to mosaic organization and thus contribute to antigenic variation (57) 
In vitro experiments (58,59) have shown that the proliferation of peripheral blood 
mononuclear cells is decreased in H. pylori infected patients compared to healthy blood 
donors. Thus some researchers have argued that H. pylori infection might lead to a 
suppression of the host cellular immune response.  
Both bacterial virulence factors and damage caused by the host inflammatory immune 
response contribute to the pathogenesis of H. pylori gastritis . 
Direct cell damage can be caused by vacA and urease, which both lead to vacuolisation 
of the gastric epithelial cell in vitro . 
Indirect damage to the host is caused by a vigorous immune response. H. pylori 
activates the proinflammatory transcription factor NF.B in gastric epithelial and 
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monocytic cells, probably via CagA dependent and independent pathways in different 
cell types (60,61). This pathway of NF.B activation, together with other pathways, 
results in epithelial production of IL-8, a chemotactic factor for human neutrophils 
(61,62). The chemotactic effect of IL-8, together with a chemotactic effect of H. pylori 
surface proteins (55), leads to an infiltration of the gastric mucosa with neutrophils and 
monocytes, causing inflammation and mucosal damage . 
H. pylori  adheres to and is phagocytosed by the infiltrating cells. Since it has been 
shown that H. pylori is able to activate a respiratory burst in human neutrophils and 
monocytes (63,64) mucosal damage may be due to the oxygen radicals produced in this 
reaction . 
Additionally, molecular mimicry between H. pylori LPS and host antigens might 
contribute to mucosal damage through autoimmune reactions. The LPS of 85% of H. 
pylori strains is composed of Lewis x and/or Lewis y antigens, human blood group 
glycoantigens whose epitopes may also be present on the beta chain of the H+/K+-
ATPase of the human gastric parietal cell. Thus H. pylori LPS is able to stimulate 
strong anti-Lewis x and anti-Lewis y responses in humans (65,66). These findings 
suggest that molecular mimicry-induced autoimmune reactions could contribute to the 
pathogenesis of H. pylori infection . 
There are data suggesting that H. pylori affects serum levels of gastrin, a peptide 
hormone that is produced by gastric G-cells and stimulates gastric acid secretion. 
Studies comparing the serum gastrin levels of healthy and H. pylori-infected 
individuals indicate that infection is correlated with increased serum gastrin levels. 
However, the acid secretion was only elevated in patients presenting with duodenal 
ulcers compared to healthy control individuals, while it was normal in asymptomatic H. 
pylori-infected patients (67). This increased acid production might also contribute to 
mucosal damage. 
1.2.7 Diseases :  
Diseases associated with H. pylori include chronic gastritis, peptic ulcer disease, gastric 
cancer and MALT-lymphoma . 
Today the bacterium is considered the main causative agent of chronic type B gastritis 
(68)  
The inflammation primarily affects the antrum and is characterized by neutrophilic and 
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lymphocytic infiltrates and distinctive epithelial    degenerative changes (69).  
H. pylori is an important risk factor for peptic ulcer disease, and infection has been 
diagnosed in 60%-100% of gastric and 90%-100% of duodenal ulcers cases, although 
in the duodenum the bacterium has only been detected in areas of gastric metaplasia 
indicating its tissue specifity (70). Eradication of H. pylori from H. pylori-positive 
peptic ulcer patients provides the most effective treatment resulting in ulcer healing and 
low frequencies of relapse (71,72)  
The chronic inflammation caused by H. pylori can result in mucosal atrophy, 
metaplasia and dysplasia, thereby creating the bases for a malignant transformation 
(73,74). Therefore Helicobacter infection is associated with an increased risk of gastric 
cancer (75,76) . 
Clinical and epidemiological studies provide data for an association of the bacterium 
and MALT lymphoma. H. pylori infection has been diagnosed in over 90% of MALT 
lymphoma patients (77), and antimicrobial eradication therapy can result in tumor 
remission in clinical studies (78). In vitro, the growth of isolated lymphoma cells 
required a T cell activation induced by H. pylori (79,80)  
1.2.8 Diagnosis: 
Various tests are available to assist in diagnosis of H. pylori infection .These test can 
be categorized into those that are based on direct assessment of gastric biopsies 
(invasive) and indirect tests (noninvasive )that detect an immunological response (i.e. 
antibodies against H. pylori ) or metabolic products (i.e.urease activity) of H. pylori 
(34) 
The gold standard for the detection of H. pylori has been defined as culture, or 
histopathological examination of gastric biopsies. Depending on the experience of the 
investigator .In order to optimize the diagnosis of H. pylori .It is usually recommended 
that several tests be used together .The choice of a particular test will depend on locally 
available facilities, cost considerations, and clinical circumstances in which the      
diagnosis of H. pylori is to be made. 
1.2.8.1 Histology: 
 
Histology is currently the gold standard for diagnosing H. pylori infection. The organ 
ism can be identified on a routine hematoxylin-eosin stain but special stain 
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(e.g.Geimsa, Warthin-starry )may be even more accurate .At least two samples should 
be evaluated, regardless of the stain used . Because H. pylori infection causes antral 
inflammation ,some investigators suggest that absence of inflammation on biopsy is the 
most dependable finding to use for exclusion of infection (negative predictive value 
100%) (3,81) . 
 
1.2.8.2 Culture : 
 
The most specific method to diagnose infection is culture of H. pylori from gastric 
biopsies, but its sensitivity depends on both the biopsy transport conditions and 
expertise available in the individual laboratory (34,82). However, H. pylori is a 
fastidious, slow growing organism that requires special culture conditions. So relying 
on culture alone can mean missing a proportion of infected cases for technical reason, 
Including overgrowth of other bacteria and low bacterial load.                                                        
Attention to transport conditions of biopsies is particularly crucial for an adequate 
diagnostic yield . Biopsy specimens should be transported in a moist state, must be 
cultured within 4-6h of being taken. Storage beyond this time should be at 4oC, or at 
20oC if the period is more than 2days. Specimens can be kept in Stuart semisolid 
transport medium for 24h if stored at 4oC (83).No transport medium is used 
universally, but the various suggested transport media for biopsy samples, include 
normalsalne,20%glucose,and Stuarts medium(84).An in-house Helicobacter transport 
medium used successfully for several years for both biopsies and cultures comprises 
brain heart infusion broth (3.5%),yeast extract (2.4%) sterile horse serum (5%)and 
antibiotic supplement (Vancomycine , Trimethoprim ,cephsoludin, amphotericin ) (85).                 
Selective media should be used together with a non selective fresh blood-based agar..in 
order to ensure optimal recovery of H. pylori, plates should be incubated in 
microaerobic environment at 37oC under humid  condition for at least 5-7 days before 
being discarded. Colonies may be visible after 3-5days of incubation but may take 
longer to appear on primary isolation.                                                                                
                     
1.2.8.3 Rapid urease test: 
H. pylori produces such abundant urease that the enzyme can be detected in specimens 
of infected  gastric mucosa placed directly in a solution of urea with phenol red as an 
indicator. In the original test, Christensen urea broth was used but unbuffered urea 
solutions .If  freshly prepared .and the use of gels instead of broth give quicker result 
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(34,86,87)A number of modifications have been described and kits are now widely 
available from commercial sources (e.g. Campylobacter-like organism(clo)test ). The 
test can have a sensitivity of at least 80% and specificity approaching 100% when the 
reaction is positive within 1h. false positive may occur by contamination with urease-
producing bacteria from the oral cavity .In clinical practice ,biopsy urease test result 
should be read within 24h It has the advantage of diagnosing H. pylori status in most 
cases soon after endoscopy, which is helpful for the clinician planning therapeutic 
interventions. Test kits are accure of gastric biopsies (34,88).                                    
 
1.2.8.4 Urease breath test : 
The urea breath test identifies active H. pylori infection through the organism’s urease 
production. The patient ingests urea labeled with either the nonradioactive isotope 
carbon 13 (13C)(Breath Tek UBT for  H. pylori, Meretek Diagnostics, Inc, Lafayette, 
CO) or the radioactive isotope carbon 14 (14C) (PY test, Kimberly-Clark Corp, Draper, 
UT). If  H. pylori is present in the stomach, hydrolysis occurs and produces Labelle 
carbon dioxide, which is detectable within a few minutes in the patient’s breath. The 
labeled urea is typically given to the patient with a test meal to delay gastric emptying 
and increase contact time with the mucosa. After urea ingestion, breath samples are 
collected for up to 20 minutes by exhaling into a carbon dioxide–trapping agent. 
Though the amount of radiation in the 14C urea breath test is less than daily 
background radiation exposure,(89,90) the 13C test is preferred in children and 
pregnant women.(91) 
Recently, a new card test for 14C urea has been described that uses a flat breath card 
that is read by a small analyzer, providing a nearpatient testing option in primary care 
settings. 
The urea breath test detects active  H. pylori infection and is highly accurate, with a 
weighted mean sensitivity and specificity from published trials of 94.7% and 95.7%, 
respectively (92) 
 
1.2.8.5 Serology : 
 
Serologic testing detects the presence of specific IgG antibodies to H. pylori in a 
patient’s serum. These antibodies are present in serum about 21 days after infection and 
can remain present long after the organism is eradicated. They can be assessed 
quantitatively using enzyme-linked immunosorbent assay (ELISA)and latex 
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agglutination techniques or qualitatively using office-based kits. Dozens of different 
serologic tests are commercially available.( 89) 
Advantages of the serologic tests are their wide availability, their rapid results, the fact 
that they require no specialized equipment or techniques, and their low cost relative to 
active tests. For these reasons, serologic tests were the mainstay of H. pylori diagnosis 
for a number of years.(89) 
The major disadvantage of serologic tests is that they cannot distinguish between active 
infection and previous exposure to H. pylori because serologic testing detects only 
antibodies, a positive serology result can occur in three very different patient 
groups(93) 
1. Those with detectable antibody and active H. pylori infection (true-positive for 
antibody, infected). 
2. Those with detectable antibody but not actively infected (true-positive for antibody, 
not infected). 
3. Those never infected and with no antibody detectable (false-positive result). 
This distinction is critical because eradication therapy is of no clinical value in the 
second and third groups. As more and more people are successfully treated for H. 
pylori in a population, the ranks of the “true-positive for antibody, not infected” group 
(group 2) will grow. Of course, the inability to distinguish between active and past 
infection also renders serologic testing useless for confirmatory testing to ensure H. 
pylori eradication following treatment to cure the infection. 
This inability to distinguish between current and past infection contributes to the other 
major shortcoming of serologic testing that it is less sensitive and specific than the 
active noninvasive tests for H. pylori (92).  
 
1.2.8.6 Stool antigen test : 
The stool antigen test is an enzymatic immunoassay (ELISA) that identifies H. pylori 
Antigen in stool specimens through a polyclonal anti- H. pylori antibody (Premier 
Platinum HpSA, Meridian Bioscience, Inc, Cincinnati, OH). In addition, a rapid stool 
antigen test (Immuno card STAT! HpSA, Meridian Bioscience, Inc, Cincinnati, OH) is 
available. Using the rapid assay, a diluted stool sample from the patient is dispensed 
into the sample port of the test device; after 5 minutes of incubation at room 
temperature, the device indicates a positive or negative result, providing a near-patient 
testing option in primary care settings(89). 
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The ELISA stool antigen test detects active H. pylori infection and is highly accurate, 
with a weighted mean sensitivity and specificity from published trials of 93.1% and 
92.8%,respectively (89,92) rates that are virtually the same as those for the urea breath 
test.  
Islam et al. (2005) evaluated the usefulness of HpSA before and after eradication 
therapy on 127 adult patients. All patients underwent HpSA testing and gastroscopy 
with biopsies. Those who were found to be H. pylori-positive received triple therapy 
of clarithromycin, amoxicillin and omeprazole for seven days. HpSA was compared 
with histology, urease testing, or a combination of the two for pretherapy testing. 
After a period of six to eight weeks, post-treatment testing for confirmation of 
eradication was done using the UBT and HpSA. The sensitivity and specificity were 
79% and 92%, respectively, for HpSA when compared to combined urease and 
histology as the reference standards. A sensitivity of 67% and specificity of 100% 
were reported for HpSA when compared to UBT used as the reference standard for 
post-treatment testing. The authors concluded that “in this prospective study, HpSA 
was found to be a reasonably useful diagnostic test for H. pylori infection .(94,95)   
      
1.2.8.7 Near patient test :  
Rapid office-based tests using whole blood have been developed as they are quick and 
easy to perform. but sensitivity and specificity vary widely .Their inaccuracy therefore 
precludes there use as diagnostic test in genral practice setting(96).     
 
1.2.8.8 Salivary and urine antibody : 
The use of commercial assays to detect  anti-H. pylori IgG antibodies in saliva or urine 
are attractive alternatives as they are completely noninvasive and easy to perform. The 
accuracy is unacceptable (sensitivity 81% and specifity 73% ) (97).However .data on 
urine antibodies assay indicate an accuracy comparable to that of the serum ELISA in 
Japanese (98) and European population (96). 
1.2.8.9 Molecular test : 
There are no commercially available assays for the detection of H. pylori in gastric 
biopsies even though several validated genus and species-specific probe hybridization 
and PCR assays have been described and have recently been reviewed (99) .The 
method with the potential for greatest sensitivity is detection of H. pylori-specific 
DNA by PCR .Gastric biopsy material and gastric juice aspirates have been used for 
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PCR diagnosis targeting various DNA sequences  including regions of 16S rRNA 
gene (100). urease subunit genes (101).The vacA gen (102).and a portion of a gene 
encoding a spescies-specific 26 kDa protein (103).Results with these PCR tests have 
yielded ranges of sensitivities and specificities depending on the material analyzed 
and the assays (99). 
Molecular techniques may be become more relevant for the diagnosis of H. pylori. 
1.2.8.10 String test : 
The swallowed string test (Enterotest ) is minimal invasive approach as an alternative 
to endoscopy for direct sampling of gastric fluid, although there is no information on 
its use in clinical practice . samling of gastric juice provides a good measure of the 
infecting strain population shed from the gastric mucosa (104) so analysis of the string 
sample by culture or PCR could be informative when its accuracy has been 
established.(34).  
1.2.9 Immunity: 
     Patients infected with H pylori develop an IgM antibody response to the   infection . 
Subsequently, IgG and IgA are produced, and these persist, both systemically and at 
the mucosa in high titer in chronic infected patents  
1.2.10 Transmission: 
Its transmission has not been completely understood. Direct person to person 
transmission is considered to be the most likely mode and it is believed that the 
transmission either follows the fecal-oral or the oral-oral route. Fecal-oral (1,38,131)  
transmission gained importance by the detection of H. pylori in the faeces of infected 
patients (132), while studies comparing the distribution patterns of H. pylori with 
Hepatitis A virus, an organism transmitted by the fecal-oral route, suggest that this 
transmission mode may be of limited importance (133). There is evidence that 
acquisition of infection takes place predominantly in early childhood (134), and the 
host usually remains infected for a lifetime.  
Transmission of the bacterium among adults seems less frequent although it seems 
favoured when there is close personal contact, as there are higher prevalences in 
institutions (135). 
 
  
  
16
1.2.11 Epidemiology: 
childhood (136,137), close person to person contact (138,139), and low socioeconomic 
status (140). Thus the prevalence of H. pylori infection ranges from approximately 20 
to 50% in industrialized countries to over 90% in developing nations (141,142). As 
determined in a study of the Robert Koch Institute in 2000, the prevalence of H. pylori 
infection for the total population of Germany is 40% (143) It is estimated that 50% of 
the world’s population is infected with H. pylori. Infection rates ،like for many other 
infectious diseases, correlate with poor living conditions H. pylori is present  on the 
gastric mucosa of less than 20% of persons under age 30 but increases in prevalence to 
40-60% of persons age 60 including persons  who are asymptomatic. In developing 
countries the prevalence of infection may be 80 %or higher in adult.   
              \ 
1.2.12 Treatment: 
 Eradication of H. pylori is probably one of the most frequently prescribed antibiotic 
based complex therapies due to the widespread rate of colonization of the bacteria in 
humans. management of H. pylori infection in different gastrointestinal diseases is 
guided by international and national guidelines and recommendations (e.g. Maastricht 
Consensus reports for Europe).(105) . 
At present, clarithromycin (Cla), amoxicillin (Am) and proton pump inhibitor (PPi) 
based triple therapy regimen constitutes the most generally accepted first line empirical 
treatment for H. pylori infected patients world-wide. However, the growing number of 
reported therapy failures has long prompted clinicians to seek more effective solutions. 
(106.107). These efforts, based mostly on empirical observations with different 
antibiotic combinations, have not led to widely accepted, conclusive therapy protocols, 
so far.  
When selecting a therapy to eradicate  H. pylori, duration of treatment and adverse 
effects should be considered (108) 
Until recently, the recommended duration of therapy for H. pylori eradication was 10 
to 14 days. The most widely recommended regimens are summarized in.37Studies 
evaluating one-, five-, and seven-day regimens to eradicate H. pylori are summarized 
in(108,109,110). 
Although not proven, potential benefits of shorter regimens include better compliance, 
fewer adverse drug effects, and reduced cost to the patient.(108) 
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1.2.12.1 Firest-line  treatment : 
The best validated first-line treatments for H. pylori include clarithromycin-based triple 
therapies consisting of a proton pump inhibitor (PPI), clarithromycin, and either 
amoxicillin or metronidazole and bismuth-based quadruple therapies consisting of a 
histamine receptor antagonist or PPI combined with bismuth, tetracycline, and 
metronidazole. Where available, ranitidine bismuth citrate (RBC) can be substituted for 
a PPI in clariithromycin triple therapy .These regimens currently yield eradication rates 
ranging from 70%–85%. Triple therapy employing a PPI with clarithromycin and 
amoxicillin is the most widely endorsed first-line regimen for H. pylori 
eradication(111,112,113) 
Any of the currently available PPIs may be used with equivalent treatment 
(114,115)With the exception of esomeprazole which can be prescribed once daily, it is 
important that the standard dose of a PPI be prescribed twice daily to maximize 
treatment efficacy.(116) RBC is sometimes used in place of a PPI in countries outside 
the United States (where it is not commercially available) with at least equal and 
perhaps greater efficacy.(117) 
Metronidazole can be used as an alternative to amoxicillin, particularly Bismuth-based  
quadruple therapy is another option in penicillin allergic patients which yields similar 
eradication rates to clarithromycin triple therapies(.118,119,120) . 
Recently, simplified twice-daily dosing regimens for bismuth quadruple therapy have 
been successfully used in clinical trials.(121) It is worth noting that the dosing of 
metronidazole used in the various bismuth quadruple therapies has not been entirely 
consistent across studies. 
As higher doses of metronidazole (500 mg) may provide better cure rates than lower 
doses (250 mg),caution must be exercised when interpreting the data from comparative 
studies and pooled analyses involving quadruple therapies. 
 
Administration for use in the United States. A recent meta-analysis of 7 studies 
involving more than 900 patients found that a 14-day course of clarithromycin triple 
therapy provided better eradication rates than a 7-day course of therapy. There was also 
a trend toward improved efficacy with10 days of therapy compared to 7 days of 
therapy which did not reach statistical significance.(122) Due to falling eradication 
rates with clarithromycin-based triple therapy, it is essential to take every opportunity 
to optimize treatment success. clarithromycin triple therapy, particularly in regions 
such as the United States where eradication rates have been 80% or less with shorter 
durations of therapy.   Although some promising data exists on the effectiveness of 
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ultra short course of therapy,(111,123,124) treatment duration of less than 7 days 
cannot currently be recommended 
 
1.2.12.2 Second-line therapies : 
 
Even with the current most effective treatment regimens,  About 10-20% of the patients 
will fail to eradicate the infection and will remain H. pylori positive after 4 weeks or 
longer .Failures are due mainly to bacterial resistance or poor compliance. Widespread 
resistance to antibiotics used in eradication therapy. In particular metronidazole and 
clarithromycin, is a source of growing concern because of its impact on eradication 
.The clinical relevance of antibiotic resistance is increasingly accepted as an issue and 
its importance in therapy has been high lighted in several recent studies (125,126) . 
An optimal strategy for retreatment after initial failure of eradication has not yet been 
established, but the recommended second line therapy according to the Maastricht II-
2000 report is use of quadruple therapy a PPI with bismuth ,metronidazole ,and 
tetracycline (an antibiotic un likely to have been used previously in front-line therapy ). 
It is advisable that the antibiotic susceptibility of the organism is determined before 
retreating because of high resistance rates in some populations to metronidazole . 
The use of ranitidine-bismuth-citrate-based triple therapy is another possibility for 
retreatment (127). 
 
1.2.12.2 Resistance:  
 
Although first-line therapy will successfully eradicate the bacteria in most infected 
patients, antibiotic resistance of H. pylori is a growing concern.(128,129 ).Resistant H. 
pylori has been documented in cases of failed eradication therapy based on biopsy and 
culture results and is of great concern in patients at high risk for complications of H. 
pylori infection. 
In one small trial, 70 percent of patients failing one or more regimens responded well 
to triple-drug therapy that included pantoprazole (Protonix), amoxicillin, and 
levofloxacin (Levaquin) for 10 days (130) A meta analysis of current literature on 
treatment of resistant H. pylori showed some benefit in using quadruple drug therapy, 
including the addition of clarithromycin to ranitidine (Zantac),bismuth, and amoxicillin 
(1g twice daily)therapy, as well as a combination of proton-pump inhibitors (standard 
dosage for 10 days),bismuth, metronidazole (Flagyl), and tetracycline. (129) 
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Regimens that include rifabutin (Mycobutin), 300 mg per day, also have been 
successful in 38 percent of resistant cases.(128). 
 
1.3.1 Medicinal plants: 
The medicinal plants were known since old ages and were handled by many people as 
traditional medicine to treat many diseases. 
Statistical purposes to use these traditional medicines were found very high in 
developing countries and Sudan is one of them. 
To use traditional medicine which was very primitive not scientifically studied for the 
right quality and quantity and the side effect on users, there are many scientific 
institution and researchers  as individual  their attention to study many plants that are 
used in traditional medicine, to extract the useful ingredient without the harmful 
material. Commiphora myrrh is one of the medicine plants that are commonly used in 
Sudan in traditional medicine for the treatment of many diseases. This plant is found in 
great quantity in North-East Africa, collected in Southern Arabia and Iran.[ 
 1.3.2. The activity of medicine plants: 
Effective efforts have been made over last fifty-year to find new antimicrobial agents 
the major part of the reported investigations was concerned with lower plants with 
special attention being paid to different species of Streptomycets and some fungi . 
However, a number of reports indicated new source of anti-microbial agents from 
higher plants (144) 
Beloy,et al(1976) studied 106 species belonging to44 families for antimicrobial activity 
9 plants showed high antimicrobial activity  
Thirty-three plants of Pakistan origin screened by Ikram and Inamul-Hag(1980) for 
antimicrobial activity (144). 
Wondergam and grand (1984) examined 33 species (used against infectious diseases 
by the diolaof southern Senegal) for antimicrobial activity. Of these 28were active 
against such organisms as Staphylococcus aureus, Bacillus subtilis and Asperigillus 
niger  (144).. 
Forty-five species of Somalian medicinal plants screened by Elmi et al (1986) for 
antimicrobial activity against (Staphylococcus aureus, Bacillus subtilis) They found 
  
  
20
that, thirty species showed activity against Gram-positive bacteria . (144). 
Elagimi et al (1998) screened 114 extracts of Sudanese plants used in folkloric 
medicine for their anti-bacterial activity against (E. coli, Staphylococcus aureus , 
Bacillus subtilis , P. aeruginosa) Of these,83,(73%) extracts showed significant anti-
bacterial activity. (144).  
1.3.3. Commiphora myrrh : 
As mentioned by Guenther(145), myrrh (also called heerabol-myrrh or bitter myrrh) 
is gum-resin obtained from several species of Commiphora (fam. Burseraceae), 
notably C. Abyssinic(Berg) Engler, oofC. schimperi (Berg) Engler, and C. myrrh 
(Nees) Engler var molmol  Engler. Genus Commiphora comprises more than 200 
species, all native to Africa, Arabia, Madagascar and India. In order to collect gum, 
the natives make incisions into the bark, causing the exudation of a yellowish oleo 
resin. Exposed to the air, this dries, hardens and turns reddish-brown..(146) 
Myrrh is partly soluble in ethanol (30 % alcohol soluble material) and is also partly 
soluble in water and in ether. Since antiquity myrrh has served as a constituent of 
incense. Oil of myrrh is a valuable ingredient in perfumes (balsamic, heavy odour). 
The chemistry of myrrh..(146). 
Commiphora myrrh (also known as Commiphora molmol and Balsamodendron myrrh) 
of the Burseraceae family and is also known as bola, Myrrh is a large shrub or small 
tree that grows in the Middle East and Ethiopia and Somalia. A pale yellow oil drips 
from the cuts in its dull gray bark and hardens to form teardrop-shaped nuggets of 
myrrh, which are powdered for use as a healing herb. (147) 
Myrrh is referred to in the Bible. It was used by Egyptians in embalming mixtures. It 
was used as an aromatic for perfumes, funerals, and insect repellents. It is used today as 
an aid to repel tooth decay and gum disease. Ancient Greek and Roman physicians 
used the herb to treat wounds and prescribed it internally as a digestive aid and 
menstruation promoter (147,148). 
Contemporary herbalists recommend adding powdered myrrh to well-washed wounds 
as an antiseptic and consider a gargle made from the herb effective against sore throat, 
colds, sore teeth and gums, coughs, asthma, and chest congestion. 
Anti-microbial, astringent, carminative, anti-catarrhal,expectorant, analgesic,antiseptic, 
antispasmodic, emmenagogue, expectorant, stimulant, rejuvenative. 
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Myrrh is an effective anti-microbial agent that has been shown to work in two 
complementary ways. Primarily it stimulates the production of white blood corpuscles 
(with their anti-pathogenic actions) and secondarily it has a direct anti-microbial effect.  
Myrrh may be used in a wide range of conditions where an anti-microbial agent is 
needed. It finds specific use in the treatment of infections in the mouth such as mouth 
ulcers, gingivitis, phyorrhoea, as well as the catarrhal problems of pharyngitis and 
sinusitis. It may also help with laryngitis and respiratory complaints.  
Systemically it is of value in the treatment of boils and similar conditions as well as 
glandular fever and brucellosis. It is often used as part of an approach to the treatment 
of the common cold. Externally it will be healing and antiseptic for wounds and 
abrasions. 
Myrrh is a common ingredient in European toothpaste to fight the bacteria that cause 
tooth decay. 
Used in traditional Chinese medicinal herbs as antineoplastic agents and antitumor  
Myrrh may help prevent heart disease. Preliminary Indian studies suggest that it 
reduces cholesterol. The herb may also help prevent the internal blood clots that trigger 
heart attack. 
Myrrh appears in British Pharmacopoeia and other modern pharmacopoeias (149)       
Tincture of myrrh, prepared by extraction with 90% alcohol,(150)is used in 
mouthwashes and gargles for its astringent effect on mucous membranes ,particularly 
for mouth ulcers, gingivitis and pharyngitis. It has also been applied to the skin for 
wounds and abrasion (151) although there are reports of contact dermatitis developing 
as a result of topical application of myrrh –containing plasters (152).Other myrrh –
containing products include toothpastes ,hairsprays, perfumes, aromatherapy oils and 
toiletries (153). Myrrh is also permitted to be used in foodstuffs in small 
quantities(154).Teething-gels containing myrrh have been used to relieve teething pain 
in infants(155). 
One of the newest developments in the uses  of myrrh has also been the most 
controversial and relates to its role in treating Schistosomiasis (148).                                               
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1.3.3.1 Active Compounds: 
Volatile oil, containing heerabolene, cadinene , elemol , eugenol cuminaldehyde, 
numerous furanosesquiterpenes including furanodiene, furanodienone, curzerenone, 
lindestrene, 2-methoxy furanodiene and other derivatives.  
Resins including a-, b- and g-commiphoric acids, commiphorinic acid, heeraboresene, 
a-and b-heerabomyrrhols and comm 
Gums, composed of arabinose, galactose, xylose and 4-O- methylglucuronic acid 
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Objective of the study 
 
General: 
To study the effects of Commiphora myrrh in clinical isolate of Helicobacter pylori 
from peptic ulcer patient . 
 
Specific:  
1. To determine The prevalence of Helicobacter  pylori in G I.T. patients. 
2. To Identify the isolates using standard  techniques.  
3. To Conduct sensitivity test to the Commiphora myrrh in comparison  
            used antimicrobial   agents with .   
                                   . 
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Materials and methods 
 
2-1 Study approach: 
Quantitative study aimed to identify causative agents of peptic ulcer disease and their  
 susceptibility testing against Commiphora myrrh and commonly used antimicrobial 
agents 
 
2.2   Study design :                                                                               
The study was designed as a descriptive study 
 
2.3   Study area :                                                                                  
The study area was facility based conducted in Khartoum state at Ibn  Sina 
 endoscopy department  
 
2-4 Study variables:                                                                               
Frequency of peptic ulcer disease, antimicrobial sensitivity. 
 
2.5 Study population:                                                                                 
  A total number of hundred patients  suffering from gastritis, duodenitis, and peptic 
  ulcer in Khartoum state at Ibn Sina hospital attending to endoscopy department  
Were included in this study. 
  
2.6   Selection criteria :                                                                                   
The selection criteria depend on the hospital attendance (in and out patients).  
only patients responding to the questionnaire 
 
2.7  Ethical clearance:                                                                              
-  Approval was obtained from University, Faculty and Department. 
- The consent was obtained ibn sina endoscopy unit hospital and from patients. 
 
2.8 Material: 
 
3.8.1  Culture media:                                                                                  
Brain Heart Infusion broth           Oxoid – England           Exp 2/2008 
Brain Heart agar                             Oxoid – England         Exp  2008  
Mueller Hinton Agar                     Oxoid - England           Exp  20011  
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2.8.2  Supplement :                                                                                  
Skirrows supplement:                                                         Exp 2008          
Vancomycin                             (10 mg/l)               
Polymyxin bsulphate                (250-300mg/l)       
Trimethoprim lactate                (5mg /l)                 
Amphotericin B                        (2mg/l)  
 
2.8.3 Antimicrobial disk              
                                                      
Amoxicillin                                  (30 ug)                          3/2008 
Tetracycline                                 (30 ug)                           3/2008 
Metronidazole                             (32 ug)                            3/2008 
Clarithromycin                            (15 ug)                            3/2008 
 
2.8.4 Chemicals & biological materials :                                
 
Gram stain  (Crystal violet,Gram Iodine ,Safranin,Ethyl Alcohol.) 
Hydrogen peroxide                        
Glycerol                                                 
Urease reagent (Urea ,Phenol red)                
Oxidase discs(tetramethyl-p&phenylene-diamine dihydrochloride ) 
Microaerophillic systems gas generation kits 
Horse serum 
Sheep blood 
 
 
2.8.5 Instruments &glass ware :   
                                                        
Autoclave                
Anaerobic jar                  
Hot air oven 
Microscope  
Incubator 
Sterile plates   
Sterile pipettes  
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Sterile containers 
Sterile tubes 
Tube racks 
Standard loop 
Slides  
 
 2.9 Methods: 
    
  2.9.1 Collection of the samples :                                                      
 
The samples were taken from 100 PUD patients by endoscopy at Ibn Sina Hospital in 
the period September 2006 to November 2007. 
Two biopsy specimens were taken from the antrum of the PUD patients one for rapid 
urease test on urea media and the other for culture on brain heart infusion broth media.                  
 
2 .9. 2 Rapid urease test :                                                                  
In sterile container 1 ml of urea media with few drops of phenol red as indicator was 
Placed .One of the two biopsy was placed in the mixture .the result observed  by the 
change of the colour from yellow to pink due to break down of urea by urease enzyme 
which is produced by the organism to give ammonia and carbon dioxide which changes 
the media PH to alkaline  that means the organism is H. pylori .                                                      
Urease test vary according to the volumes of  broth or agar, concentration of urea and 
phenol, and incubation temperature.                                                 
 
2.9.3 Culture:                                                                                    
 Isolation of H. pylori by culture is available diagnostic technique even a small number 
of organisms in the biopsy specimen is sufficient to provide a positive culture.  To 
obtain optimal result it necessary to take great care in  the preparation and 
transportation of the specimen (3). A culture can be performed on solid or liquid media 
.In clinical practice, a culture is required mainly if antibiotic sensitivity is to be tested .      
To isolate H. pylori the other biopsy specimen was placed in brain heart             
infusion broth as transport media ,then it was homogenized and inoculated in brain 
heart agar supplemented with Skirros’s supplement (Vancomycin, Polymyxin B 
sulphate, Trimethoprim lactate )and sheep or horse blood and  incubated for 5-7 days 
under microaerophllic condition (156 ) campy pack systems.(34)                  
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The organisms were identified by colonial morphology, gram stain and biochemical 
tests (urease, catalase and oxidase ).                                                                   
  
2. 9.4 Identification of the isolates:                                                         
2 .9.4.1 Colonial morphology                                                             
   
The significant growth of colonies were examined morphologically for size,         
  Consistency, convex and ability to haemolysis .                                                    
 
2.9.4.2 Gram staining :                                                                                    
 
The gram staining reaction used to help identify pathogens in specimens and cultures 
by their gram reaction (gram positive or gram negative ) and morphology .(157).                            
Gram stain used in routine identification , the bacteria film fixed and stained with 
triphenyl methane dye  basic dye such as crystal violet treatment with iodine solution 
and subsequently treated with alcohol, those bacteria which retain the dye are gram  
positive and those varieties of bacteria which loose the dye are gram-negative 
(3,34,157).Decolorized cells were stained by counter stain such as safranin red . The 
organisms were smeared in clean slid. The smears were allowed to dry in air and then 
fixed by gentle flaming. The slides were placed on the staining rack  and flooded with 
crystal violet stain for one   minute, Washed rapidly with clean tap water, covered with 
lugol`s iodine for one minute , Washed rapidly with clean tap water .All the smears 
decolorized rapidly with alcohol (few second ) and wash immediately with clean tap 
water ,The smears covered with counter stain neutral red for one minute. The stain was 
washed  with clean tap water.                                                                                                           
The slides were placed in the slides rack for the smear to air dry ,Then the smears  were 
examined microscopically using oil immersion objective and the results reported                            
The organisms were gram negative bacilli .                                                      
 
2.9.4.3 Urease test                                                                                         
 
Testing of urease enzyme activity is important to differentiating the urease          
 producers bacteria.                                                                                       
The test organism is cultured in medium which contains urea and the                 
indicator phenol red . when the strain is urease producing the enzyme will break down 
the urea by hydrolysis to give ammonia and carbon dioxide.            
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With the release of ammonia medium change to alkaline as shown by change in colour 
of indicator to pink colour(157)                                                         
In this work some colonies from each isolate were emulsified in 1 ml of urea reagent 
with phenol red in sterile tube, the organism which were urease producer will 
hydrolyze the urea to give ammonia and change the PH to alkaline to produce pink 
colour.                                                                                  
 
2.9.4.4 Catalase test :                                                                                    
  
This demonstrates the presence of catalase enzyme that catalyses oxygen from hydrogen 
peroxide (157).and used to differentiate those bacteria that produce the catalase 
enzyme(157).                                                         
  A colony was picked by platinum loop or wooden stick and placed in 3% hydrogen   
  peroxide solution in sterile tube                                                                         
Catalase enzyme acts as a catalyst in the break down of hydrogen peroxide to oxygen 
and water with immediate effervescence occurred which indicated positive result.                          
 
2.9.4.5 Oxidase test:                                                                        
This test depends on presence in bacteria of certain oxidases that will catalyze the 
transport of electrons between electron donors in the bacteria and a redox dye-
tetramethyl-p-phenylene-diamine. The dye is reduced to deep purple color(164).                           
The isolates  were smeared in oxidase reagent strip the phenylene-diamine in the 
reagent oxidized to deep purple color(157).                                                             
 
2.10 Sensitivity test :                                                                            
Laboratory antimicrobial sensitivity testing can be performed using             
The  dilution technique                                                                           
The  disc diffusion technique.                                                                   
In this work the two methods were used .                                                 
 
2.10.1 Inoculums’ preparation:                                                             
H. pylori strain from gastric biopsy specimens were isolated on brain heart agar and 
stored at - 80 0C in glycerol media (Brain heart broth with 25% glycerol).                                        
The isolate were incubated in brain heart agar supplemented with 10% horse blood 
(158) for 48h at 37oC under microaerophilic condition ,produced as described above. 
Given the importance of inoculum homogeneity (158,159), cellular viability was 
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controlled microscopically by morphological observation with gram stain, cultures 
were always used after 48h of incubation when they generally didn't present coccoid 
forms(160) Suspensions were prepared in sterile normal saline to an opacity of 
McFarland standard (ca109cFU/ml).(158.161). 
 
 
2.10.2. Disc diffusion method :                                                  
 Disc diffusion techniques are used by most laboratories to test routinely for 
antimicrobial sensitivity. A disk of blotting paper is impregnated with a  known volume 
and appropriate concentration of antimicrobial. not more than six discs should be tested 
on a single plate to avoid fusion of inhibition zones to each other.                 
Modified Kirby-Bauer sensitivity testing technique was used Mueller Hinton 
sensitivity testing agar prepared and sterilized and cooled then treated with horse serum 
and poured in sterile Petri dishes to depth of 4mm. The prepared media was solidify 
and dried (162).                                              
The prepared inoculums were inoculated in the media with sterile loop.              
The antimicrobial discs (Amoxicillin, Claritheromycin, Metronidazole, Tetracycline). 
Were picked by sterile forceps and places on the surface of the inoculated media and 
pressed lightly by the forceps to make contact with media to allow the antimicrobial to 
diffuse from the disc to the media .       
The plates ware incubated at 370C for 2-3 dayes under microaerophilic condition. 
(Campy-pak system).The culture was examined for zones of inhibition of bacterial 
growth around the respective disks.                                              
 
  2.10.4 Agar dilution method:                                                
The principle of the agar plate dilution method is the inhibition of growth on the 
surface of the agar by the antimicrobial agent (plant extract) incorporated into the 
medium. 
The organisms tested were prepared in sterile normal saline to an opacity of McFarland 
standard (ca109cFU/ml).(158,161).                                              
A loop full of the diluted culture is spotted with a standard loop that delivers 0.001ml 
on the surface of the media .  
Sterile screw cap tubes were numbered .All the following steps were cared out using 
aseptic technique.                                                                       
1ml of Commiphora myrrh extract was added to 10 ml of methanol as the first tube and 
10ml of sterile distilled water was added to all other tube.                
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10 ml transferred from the first tube to the second tube and mixed well with separate 
pipette and transferred 10 ml to the third tube.                                   
  The dilution was continued in this manner to tube number 5and the pipettes changed                
between tube to tube to prevent carry over of extract on the external surface of the 
pipette .10 ml removed from tube 6 and discarded .             
Tube 6 which served as a control, no Commiphora  added to it.                     
Muller-Hinton media prepared in dabble concentration for amount of the media to 20 
ml of D.W only 10 ml were used and autoclaved and cooled and supplemented with 
horse serum and the diluted extract added to it , mixed and transferred to the plate.                         
After one drop of the suspension transferred to the plate .Incubated at 370C    
for two days and the result observed by growth or no growth                        
The highest dilution without growth is the minimum inhibitory concentration 
  
 
2.11 Data analysis:                                                                                                 
The data collected was analyzed using statistical package for Social Science for 
 Personal Computer (SPSS/PC). Difference was considered significant at P value 
 <0,05 and 95% Confidence Interval                                                                  . 
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Results 
Hundred Specimens of antrum  biopsy  were taken by physician from Sudanese 
patients with Peptic ulcer disease who attended during the period October  2006- 
November 2007  
 
3.1 Demographic features of study population:- 
3.1.1 Gender And Age  : 
 
Demographic features of the patients included in the study 52 female and 48. 
(fig 1) and age ranged between 19 – 70 years which as classified in the study to  
be > 40 =64% and <40 =36 % .(Table 1) . 
 
 
3.1.2 Residence distribution:- 
 
Most of the patients were from Khartoum state 62%, 14% from the North, 5% from the 
East Sudan and from the West Sudan 4% and 10 from Southern Sudan and from 
Central Sudan 5% .( fig 2)  
 
3.1.3 Occupation distribution: 
 
The study population distributed according to there jobs to 32 manual workers, 31 
house wives and 15 students , 6 farmers and 16 other jobs (Doctors ,Employers 
,Engineers and  Teachers). (fig 3).  
 
3.2 Endoscopy results: 
 
The study population included 15 Gastritis, 4 Duodenitis, 32 both Gastritis & 
Duodenitis, 14 Duodenum ulcer ,5 Gastric ulcer and 2 with Esophagus variesis and 5 
with both Gastric ulcer & Duodenum ulcer ,2 were Gastric hernia 8 with both Gastritis 
& Duodenum ulcer and 3 with Gastritis & Esophagitis & duodenum ulcer 7 were with 
Gastritis and esophagitis .(fig 4)  
[ 
3.3 Rapid urease test results:  
In the hundred specimen 86% were showed positive rapid urease test and  14%  
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negative for urease test. (Table 2). 
3. 4 Culture results:  
 
Sixty   showed positive growth and fourty were negative  growth .(Table 3)  
60 of urease positive showed positive growth and 26 no growth, none of negative  
urease showed growth (table 4). 
The growth rate in women was higher than in men 53.4%: 46.6 % respectively (table 5)  
In the study population there were high positive growth in house wife 23, manual  
workers 19 , 7 students and 5 farmers  and 6 others ( table 6) . 
Positive culture growth were high in Khartoum state (Table 7).  
  Endoscopy findings  showed high growth rate in Gastritis  &  duodenitis 21  and 
  duodenum ulcer 9 and 7 and Gastritis  duodenal ulcer and gastritis 5and 4 Gastric  
ulcer & duodenal ulcer And 3 duodenitis and 3 gastric ulcer and the same number  
Gastritis & esophagitis .& duodenal ulcer and 2 Gastritis & gastric ulcer and 2  
Gastritis & esophagitis . and one esophagus varaesis and there were no growth in 
 esophagitis . nor in  gastric hernia Fig (5). 
 
3.5 Sensitivity test  results: 
3.5.1 Antibiotic disk results: 
 
The susceptibility tests for sixty H .pylori isolates were determined by the Kirby Bauer 
disk diffusion technique against(Amoxicillin, Metronidazole, Tetracycline  
,Clarithromycin  ). 
The sensitivity assessment showed high resistance rate in Clarithromycin and 
Metronidazale  and high sensitivity to Amoxicillin and then to Tetracycline (fig 6, 7, 8, 
9).  
 
3.5.2 Plant antimicrobial results: 
 
The plant antimicrobial activity was determined by agar dilution method to plant 
extract  against  H. pylori isolates and which showed high sensitivity 100%  in dilution 
one (1/20) and 90%  in dilution two (1/40) and in the third dilution (1/80) the 
sensitivity  50% (30 out of 60) and the sensitivity decrease in dilution four to (1/160) 
20%  (fig10,11,12,13). 
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Fig (1) 
               Gender distribution and percentage in study population.  
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Table (1) 
 
            Age distribution and percentage in study population. 
 
  
Age Number of patient Percentage 
 >40 64 64.0% 
  <40 36 36.0% 
   
Total 100 100.0% 
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Fig (2) 
       
            Distribution of the study population  according to their residence  
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 Fig (3)             
 
           Distribution of the study population  according to their Occupation .  
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Fig (4) 
              
         Distribution of study population according to Endoscopy results  
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Table (2) 
           
 
                    Results of Rapid urease test in hundred GIT biopsy                               
                                                                                                     
 
 
 
 
 
 
 
Rapid urease test  
Number of biopsy  
 Percentage 
positive 86 86   % 
negative 14 14   % 
Total 100 100 % 
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     Table (3) 
                 
                  Percentage of the growth in one hundred GIT biopsy 
                  
Culture Number of  biopsy Percentage 
 Growth 60 60  % 
 No growth 40 40   % 
 Total 100 100 % 
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        Table (4) 
         
                    
                   Relation ship between the growth and urease results. 
 
 
 Culture Rapid urease test Total 
  positive negative   
 growth 60 0 60   % 
   
no growth 26 14 40   % 
             
            Total 86 14 100 % 
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Table (5) 
 
              Relation between Gender In the study population and growth. 
      
Gender Culture 
           
Total 
 Growth No growth  
 Male 56 % 44 % 48 
 Female   63 %  37 % 52 
           Total 60 % 40 % 100 
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  Table (6) 
 
          Relation ship  between Occupation in the study population and  
           growth of  H. pylori .       
    
Occupation Culture Total 
 Growth No growth  
House-wife 74% 26% 31 
Manual  workers 59% 41% 3 
Students 47% 53% 15 
Farmers 83% 17% 6 
 Others 39% 62% 16 
             Total   60% 40% 100 
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Table (7) 
 
           Relation ship between residence of the study population and growth.   
 
Residence Culture Total 
 growth 
no 
growth  
Khartoum          60  % 40 % 62 
North  Sudan 64  % 36 % 14 
East  Sudan 40  % 60 % 5 
West  Sudan 100 % 0   % 4 
South  Sudan 60  % 40 % 10 
Central Sudan 40  % 60 % 5 
        Total 60  % 40 % 100 
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Fig (5) 
   
  Relation ship between endoscopy finding of the study population and growth.   
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Fig (6) 
 
            Sensitivity and resistance of H. pylori to Clarithromycin.  
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Fig (7)       
 
             Sensitivity and resistance of H. pylori to Metronidazole .                                                 
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Fig (8) 
  
             Sensitivity and resistance of H. pylori to Amoxicillin.              
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   Fig (9) 
               Sensitivity and resistance of H. pylori to Tetracycline. 
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Fig (10)         
Sensitivity and resistance of H. pylori to Commiphora myrrh extract in dilution one 
(1/20) 
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   Fig (11) 
Sensitivity and resistance of H. pylori to Commiphora myrrh extract in dilution tow 
(1/40) 
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 Fig (12) 
Sensitivity and resistance of H. pylori to Commiphora myrrh extract in dilution 
three (1/80). 
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Fig (13 ) 
Sensitivity and resistance of H. pylori to Commiphora myrrh extract in dilution 
four(1/160) . 
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Discussion 
 
In the present study the prevalence  of  H .pylori infection observed was higher in 
women than men, this confirmed what found in the studies that were done in Khartoum 
teaching hospital and Academy Charity teaching hospital, Soba hospital and Ibin Sina 
hospital (3,163,164) and similar to that reported in  the study done in Ninth people`s 
Hospital of Shanghai (165). 
 
    In this study the prevalence of H. pylori infection was high among elderly as it was 
observed in the study done by Gunaid et al (166) which found that there was 
significant difference in prevalence of H .pylori infection between age group 41-75 
year (90%) and age group 16 -36 years (75%) (166,167) and similar to study done by 
Duggan and Duggan (2006)(13) found that H . pylori colonization rates remained high 
in the elderly and also in agreement with the study done in King Faisal University 
(168).  
In this study, although most of study  population came from Khartoum state but 
originally  were from the rural areas of Khartoum. This agree with the study that  found  
urbanization and the crowded living conditions of expanding cities might result in 
decline in hygiene for large sections of the population . This phenomenon may be 
associated with a concomitant rise in exposure and prevalence of H . pylori infection 
(166,168 ). And also in agreement with the study which it  found that 60% of the 
patients were originally from rural areas (3).This may explain that H .pylori infection is 
common in poor areas and another study that showed the infection in rural population 
had been higher than that of an urban population (169) . 
In this study, most of population are manual workers (32%) , 31% were house wives 
and 15 % students , 6% farmers and all other jobs (Doctors ,Employers , Engineers and 
Teachers) were16%.. 
In this study the sensitivity of urease test was high  86%  and the specificity compared 
with the culture as gold standard method was 71.4% . The high sensitivity is similar to 
that in study done in Sana`a (166) and also agree with the study done in Ibn Sina 
Hospital (170) and similar to the study that was done by Thillanyagam et al who was 
found that the sensitivity was 83% (171) and slightly high from that in study done in 
South Africa 71% (172). This sensitivity did not confirm the higher sensitivity reported 
by Marshall etal 1987 which was found to be 99% (173) . 
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  In This study there were 32 cases of both  Gastritis & Duodenitis and 15 Gastritis, 
4Duodenitis, and, 14 were Duodenum ulcer and 5 with Gastric ulcer and 2 with 
Esophagus variesis and 5 with both Gastric ulcer &  Duodenum ulcer and 2 were 
Gastric hernia 8 with both Gastritis & Duodenum ulcer and 3 with  Gastritis &  
Esophagitis & duodenum ulcer 7 were with Gastritis and esophagitis This showed that 
the endoscopic appearance of ulcer and inflammation is acute and active in most of the 
patients which agreed with the studies  done in Soba Hospital and Khartoum Teaching 
Hospital and Academe hospital (3, 163) .  
In this study susceptibility of H . pylori to antimicrobials among Sudanese patients 
with peptic ulcer disease was determined by agar dilution method for the plant 
Commiphora myrrh and disk diffusion to antibiotic disks ( Metronidazole ,Amoxicillin, 
Tetracycline, Clarithromycin). 
 
Metronidazole: 
The resistance of H. pylori to Metronidazole varies from population to population 
(168,174,175,176) It is highest in the developing and lowest in developed countries 
(174,175,177) .In this study, the prevalence of Metronidazole  resistant H .pylori 
isolates was 61.7 %; it is similar to the study done In Sudan at Ibn Sina Hospital which 
found the resistance rate was 61% (170). This high resistance rate is similar to finding 
in the study done in urban Asia population 62% (178) also the results of the present  
study agreed with the results of study done in Japan which observed that a higher 
prevalence of Metronidazole -resistant strains is seen in the western or southern regions 
although it was very rare in northern region of Japan and in Japan generally; this was 
explained   differ by the close proximity of these regions to other Asian countries,  
which have a high prevalence of Metronidazole -resistant H. pylori. South and West 
Japan are much closer to these countries than North Japan  (179). 
It also agreed with the results of the study done in King Fahd  Hospital of university 
Khobar which found high prevalence of Metronidazole -resistant H. pylori(180) and it 
was slight high than resistance rate reported from Bahrain ,Gulf region which found 
those  who were  infected by resistant strains to  Metronidazole were 57% (181.) 
Resistance of H .pylori to Metronedazole is related to the previous exposre to the drug 
(174,175,182) It has been suggested that the high  prevalence rate of Metronidazole -
resistant H. pylori in women may be due to it use in the treatment of vaginal infections 
such as trichomoniasis and Gardnerella and as prophylaxis in uterine surgery (182) 
.Previous use for the treatment of amoebiasis and other diarrheal diseases and possible 
increased use for protozoal and anaerobic infection . 
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Clarithromicin  
The likelihood of antibiotic resistance varies by geographical Region.. Additionally, 
prior use of clarithromycin or metronidazole for any infection, has been shown to 
increase the likelihood of H pylori resistance to these agents(183). Clarithromycin 
resistance varies from less than 5% in southern parts of Europe to greater than  
20% in northern Europe(195) to as high as 80% in some developing countries. (184) 
which was agreed with the finding of study that showed high prevalence of 
Clarithromycin- resistant H .pylori ,also agreed with the study done in Japan(179) and 
that one done in Singapore (185) . 
 
Amoxicillin  
Antibiotics. Amoxicillin, a semi-synthetic penicillin, is an effective antibiotic for H. 
pylori infection. The frequency of amoxicillin resistant H. pylori organisms is low. The 
drug rapidly accumulates in anural mucosa via systemic circulation. Its antimicrobial 
activity against H. pylori depends on the pH level; the minimal inhibitory concentration 
(MIC) decreases as the pH increases. (186). 
The highest prevalence of sensitivity detected was against Clavunlinated Amoxicillin 
which agreed with the study done in the Gemelli hospital of Rome  that showed the 
highest sensitivity rate in Amoxicillin (187) and also with the study done in Japan 
(179) and it was higher than that of study done in United states which  found the 
resistance  rate to Amoxicillin 1.4% (188).Data collected in 1998- 2002 found the 
reissuance rate was 9 %(189). It appears that Amoxicillin  resistance have remained 
relitatively stable .and highest from the study done in India which found that  0.9% of 
isolates were resistant to Amoxicillin (190).Reports of resistance to amoxicillin have 
been extremely rare.(191,192). 
Tetracycline 
Helicobacter pylori resistance to Tetracycline was not reported until 1996., when 
Midolo and colleagues reported Tetracycline resistant strains from Australia (193,194), 
and the studies done in Italy 1997 (193,195 ) that found 8% of strain were Tetracycline 
resistant     
In this study the prevalence of H . pylori susceptible strain were 61.7% this high 
sensitivity is slightly higher than that study done in Ninth people`s Hospital of 
Shanghai that were found the sensitivity was 58% (193) and  from the study done in 
Douala General Hospital, Cameroon which found that Tetracycline susceptibility rates 
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were 56% (196). This prevalence of high H . pylori susceptibility rate were lowest from 
the rate in  study done in India which was  found all the  isolates were sensitive to 
Tetracycline (190).. 
Antibiotic treatment of H. pylori infection is not without risk. Antibiotic therapy can 
lead to the development of pseudomembranous colitis, a potentially severe infection 
caused by Clostridium difficile. In addition, antibiotics frequently enable the 
overgrowth of Candida albicans, which can result in vaginitis, gastrointestinal 
disturbances, or other complaints. Moreover, antibiotic treatment could  lead to the 
overgrowth of antibiotic-resistant strains of H. pylori, making further attempts at 
eradication more difficult. (32). 
Investigations into plant materials as alternative sources of antimicrobials have become 
more common over the past few years, due to the increased rate of development of 
antibiotic resistant organisms. New strategies to combat infection are also being sought 
and one such strategy is the use of ‘anti-adhesive’ molecules, targeting the primary step 
of infection - adhesion of the organism to host tissue (197,198). 
In this study, H. pylori showed  high sensitivity rate to extract of Commiphora myrrh 
which were 100% in dilution one ,90% for dilution two ,60%dilution three and 20% for 
dilution four that was shown as the MIC at dilution one1/20.  
This high sensitivity was similar to other studies done on other bacteria and 
microorganisms . The only one study done on effect on gastric ulcers done by Al-Harbi 
and et al (1994) in rats who was investigated the extract of myrrh for its ability to 
protect the stomach lining against laboratory-induced ulcers in rodents.   They found 
that pre-treatment with myrrh resulted in a dose-dependent protection against 
ulceration (199).   
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Conclusion 
 
 
 
The high  rate of resistance in our patients would suggest that sensitivity testing to  
alternative treatment against Helicobacter pylori is necessary.  
Commiphora myrrh has wide-spectrum antimicrobial activity and it can investigated as 
alternative treatment against Helicobacter pylori.  
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Recommendation 
 
Due to the high rate of resistance to available anti-infective agents,  Commiphora 
myrrh can be examined as an alternative treatment on  H. pylori. 
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